Affiliation: University of Miami
- How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?Jennifer B Marks
Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 NW 10th Avenue, Miami, FL 33136, USA
Nat Clin Pract Endocrinol Metab 4:490-1. 2008..The implications of these observations for clinical practice are discussed...
- Perioperative management of diabetesJennifer B Marks
Department of Medicine, University of Miami School of Medicine, Miami, Florida 33136, USA
Am Fam Physician 67:93-100. 2003..Frequent monitoring of electrolytes and acid-base status is important during the perioperative period, especially in patients with type 1 diabetes because ketoacidosis can develop at modest levels of hyperglycemia...
- Insulin analoguesJennifer Marks
University of Miami School of Medicine, Miami, FL 33136, USA
Postgrad Med 112:8-12. 2002..The long-acting analogues, such as insulin glargine and insulin detemir, mimic the insulin secretory profile of basal insulin. Together, they approximate physiologic insulin secretion...
- Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week studyPhilip Raskin
University of Texas, Southwestern Medical Center, Dallas, Texas 75390 8858, USA
Diabetes Care 26:2598-603. 2003..Compare the efficacy, safety, and patient satisfaction of continuous subcutaneous insulin infusion (CSII) therapy with multiple daily injection (MDI) therapy for patients with type 2 diabetes...
- Diabetes TrialNetJennifer Marks; Fiscal Year: 2007..If not prevented, a treatment effect that preserves beta-cell function in those who do develop diabetes will provide an important clinical benefit. ..